Financial Times: More than 60 drugs are in advanced testing, with cheaper semaglutide versions on the way. China has the manufacturing scale to produce these treatments at a fraction of their list prices. Partnerships with global pharma groups suggest that some Chinese-developed molecules are competitive with leading global treatments, even if many remain early stage…
China to drive weight-loss drug price war
Subscribe
Login
0 Comments
Oldest